procainamide has been researched along with Scleritis in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Scleritis: Refers to any inflammation of the sclera including episcleritis, a benign condition affecting only the episclera, which is generally short-lived and easily treated. Classic scleritis, on the other hand, affects deeper tissue and is characterized by higher rates of visual acuity loss and even mortality, particularly in necrotizing form. Its characteristic symptom is severe and general head pain. Scleritis has also been associated with systemic collagen disease. Etiology is unknown but is thought to involve a local immune response. Treatment is difficult and includes administration of anti-inflammatory and immunosuppressive agents such as corticosteroids. Inflammation of the sclera may also be secondary to inflammation of adjacent tissues, such as the conjunctiva.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Scleritis developed in a patient using procainamide as part of a drug-induced lupus syndrome." | 7.67 | Scleritis as the presenting manifestation of procainamide-induced lupus. ( Slamovits, TL; Turgeon, PW, 1989) |
| "Scleritis developed in a patient using procainamide as part of a drug-induced lupus syndrome." | 3.67 | Scleritis as the presenting manifestation of procainamide-induced lupus. ( Slamovits, TL; Turgeon, PW, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turgeon, PW | 1 |
| Slamovits, TL | 1 |
1 other study available for procainamide and Scleritis
| Article | Year |
|---|---|
Scleritis as the presenting manifestation of procainamide-induced lupus.
Topics: Aged; Antibodies; Antibodies, Antinuclear; Diagnosis, Differential; Female; Histones; Humans; Lupus | 1989 |